Takeda Pharmaceutical Co Ltd SEC filings TKPHF
Takeda Pharmaceutical Co Ltd has 710 filings in SEC EDGAR's recent list, going back to Mar 5, 2007. Its latest annual report, Form 20-F, was filed on Jun 17, 2026 for the period ended Mar 31, 2026. The most recent current report (Form 6-K) was filed on Oct 29, 2026.
| Form | Description | Filed | Period |
|---|---|---|---|
| 20-F | Annual report (foreign issuer) | Jun 17, 2026 | Mar 31, 2026 |
| 20-F | Annual report (foreign issuer) | Jun 25, 2025 | Mar 31, 2025 |
| 20-F | Annual report (foreign issuer) | Jun 26, 2024 | Mar 31, 2024 |
| 20-F | Annual report (foreign issuer) | Jun 28, 2023 | Mar 31, 2023 |
| 20-F | Annual report (foreign issuer) | Jun 29, 2022 | Mar 31, 2022 |
| 20-F | Annual report (foreign issuer) | Jun 29, 2021 | Mar 31, 2021 |
| 20-F | Annual report (foreign issuer) | Jun 24, 2020 | Mar 31, 2020 |
| 20-F | Annual report (foreign issuer) | Jun 27, 2019 | Mar 31, 2019 |
| ARS | Annual report to shareholders | Jun 16, 2008 | Mar 31, 2008 |
| ARS | Annual report to shareholders | Jun 15, 2007 | Mar 31, 2007 |
| ARS | Annual report to shareholders | Mar 5, 2007 | Mar 31, 2005 |
| ARS | Annual report to shareholders | Mar 5, 2007 | Mar 31, 2006 |
Showing 12 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- TAK (NYSE), TKPHF (OTC)
- Headquarters
- Tokyo, Japan
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1395064
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.